The European Medicine Agency’s (EMA) Policy on Publication of Clinical Data for Medicinal Products for Human Use (“EMA Policy”)is now effective as of January 1, 2015. Across the Atlantic, the U.S. Institute of Medicine (IOM)...more
In this issue:
- (i) USA
- (ii) EU
- (iii) China
- (iv) Australia
- (v) Japan.
- Featured Articles:
- (i) Caffeinated Energy Drinks - a Global Perspective
Originally published in Medical Research Law & Policy Report, 12 MRLR 4, 01/02/2013.
Regardless of what happens with the fiscal cliff negotiations in Congress and the Obama administration, research funding will...more